Vie Ventures is a firm dedicated to bridging venture capital with disease-focused philanthropy to accelerate transformative therapies for autoimmune disease. 

We invest in emerging therapeutics for autoimmune and immune-mediated diseases, an area of high unmet medical need and growing scientific opportunity. Our focus is primarily on Series B and C-stage biotech companies, where thoughtful capital and strategic collaboration can meaningfully accelerate progress. 

Vie works in close partnership with leading disease foundations including the Crohn’s & Colitis Foundation, Lupus Research Alliance, National MS Society, Scleroderma Research Foundation, Sjogren's Foundation and others to align investment decisions with patient needs and scientific insight. 

Our goal is to help translate promising science into approved therapies, advancing both patient outcomes and investor returns.

Vie Ventures

Org chart

Teams

Offices